Adaptive resistance to PI3Kα-selective inhibitor CYH33 is mediated by genomic and transcriptomic alterations in ESCC cells

por Wang, Yu-xiang, Zhang, Xu, Ma, Qing-yang, Hu, Lan-dian, Zhang, Xi, Wang, Yi, Xu, Lan, Yang, Chun-hao, Tan, Cun, Kong, Xiang-yin, Ding, Jian, Meng, Ling-hua
Publicado 2021

PI3Kα inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8(+)T cells and promoting fatty acid metabolism

por Sun, Pu, Zhang, Xi, Wang, Rong-Jing, Ma, Qing-Yang, Xu, Lan, Wang, Yi, Liao, Hui-Ping, Wang, Hai-Long, Hu, Lan-Dian, Kong, Xiangyin, Ding, Jian, Meng, Ling-Hua
Publicado 2021